| 1 |
27500457 | Bendamustine increases interleukin-10 secretion from B cells via p38 MAP kinase activation. | 2016 Oct |
1 |
| 2 |
21454214 | Bendamustine therapy in patients with relapsed or refractory Waldenström's macroglobulinemia. | 2011 Feb |
1 |
| 3 |
21624007 | Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. | 2011 Sep |
1 |
| 4 |
15621757 | Bendamustine/Mitoxantrone/Rituximab (BMR): a very effective, well tolerated outpatient chemoimmunotherapy for relapsed and refractory CD20-positive indolent malignancies. Final results of a pilot study. | 2004 Dec |
2 |